Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 14.18% vs -52.51% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 76.83% vs -70.78% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -19.60% vs -72.60% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 14.74% vs -27.48% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Natco Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 14.18% vs -52.51% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -39.47% vs 14.29% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 76.83% vs -70.78% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -34.11% vs 5.25% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -19.60% vs -72.60% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -76.72% vs 10.22% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 14.74% vs -27.48% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 6.86% vs 64.52% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






